COLLEGIUM PHARMACEUTICAL, INC 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market Information Our common stock is publicly traded on the NASDAQ Global Select Market under the symbol “COLL” since May 7, 2015. Prior to May 7, 2015, there was no public trading market for our common stock. Holders As of January 31, 2022, there were 18 holders of record of our common stock. The number of holders of record does not include beneficial owners whose shares are held by nominees in street name. Dividends We have never declared or paid cash dividends on our common stock, and we do not expect to pay any cash dividends on our common stock in the foreseeable future. Stock Performance Graph The following graph shows a comparison from May 7, 2015, the date on which our common stock first began trading on the NASDAQ Global Select Market, of the total cumulative shareholder return on an assumed investment of $100.00 in cash in our common stock as compared to the same investment in the NASDAQ Composite Index and the NASDAQ Biotechnology Index, all through December 31, 2021. Such returns are based on historical results and are not intended to 39 Table of Contents suggest future performance. Data for the NASDAQ Composite Index and NASDAQ Biotechnology Index assume reinvestment of dividends, however no dividends have been declared on our common stock to date. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, December 31, $100 investment in stock or index ​ May 7, 2015 2020 2021 Collegium Pharmaceutical, Inc. (COLL) ​ $ 100.00 $ 162.98 $ 151.99 NASDAQ Composite Index (IXIC) ​ $ 100.00 $ 260.60 $ 316.35 NASDAQ Biotechnology Index (NBI) ​ $ 100.00 $ 132.14 $ 131.30 ​ The performance graph and related information shall not be deemed to be “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act, except to the extent that we specifically incorporate it by reference into such filing. Recent Sales of Unregistered Securities There were no unregistered sales of equity securities during the period covered by this Form 10-K. ​ 40 Table of Contents Purchases of Equity Securities by the Issuer and Affiliated Purchasers ​ The following table sets forth shares of Common Stock repurchased under our Repurchase Program, as well as shares transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of performance share units and restricted stock units during the three months ended December 31, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Period (a) Total number of shares purchased ​ (b) Average Price Paid per Share ​ (c) Total number of shares purchased as part of publicly announced plans or programs (1) ​ (d) Maximum approximate dollar value of Shares that may yet be purchased under the plans or programs October 1, 2021 through October 31, 2021 244,318 ​ $ 20.19 ​ 244,318 ​ 77,588 November 1, 2021 through November 30, 2021 1,047,359 ​ $ 19.52 ​ 1,047,359 ​ 57,139 December 1, 2021 through December 31, 2021 — ​ $ — ​ — ​ 57,139 Total 1,291,677 (2) ​ $ 19.65 ​ 1,291,677 (2) ​ ​ ​ (1) The Repurchase Program was announced on August 16, 2021. The Repurchase Program provides for the repurchase of up to $100 million of outstanding shares of our common stock at any time or times through December 31, 2022. The Repurchase Program did not expire during the three months ended December 31, 2021, nor does the Company currently plan to terminate the Repurchase Program prior to expiration. However, there can be no assurance as to the timing or number of shares of any repurchases in the future. (2) The difference, if any, between the total number of shares purchased and the total number of shares purchased as part of a publicly announced program relates to common stock withheld by us for employees to satisfy their tax withholding obligations arising upon the vesting of performance share units and restricted stock units granted under our Amended and Restated 2014 Stock Incentive Plan. ​ Item 6. [Reserved] ​